Vaccines Market-Size, Share, Trends & Forecast to 2030

Vaccines Market Data Product Overview

The Vaccines Market data product from Next Move Strategy Consulting provides market sizing, forecasts, segmentation, regional analysis, and competitive intelligence for the global vaccine industry. The market is projected to reach USD 115.08 billion by 2030, growing at a CAGR of 5.5% from 2025 to 2030. The report evaluates vaccine technology platforms, including live attenuated, inactivated, subunit and recombinant, polysaccharide and conjugate, toxoid, viral vector, and messenger RNA vaccines. It covers disease indications, routes of administration, target populations, end users, regional markets, and key industry participants. Research combines primary expert interviews conducted on an aggregated basis with secondary research from proprietary databases and industry sources. The dataset is delivered in PDF and Excel formats.

Use Cases

• Market Entry Assessment: Evaluate growth opportunities across vaccine technologies, disease indications, target populations, and geographic markets using the forecast through 2030.

• Competitive Benchmarking: Assess the competitive landscape involving companies such as Merck & Co., Pfizer, GSK, Sanofi, Moderna, BioNTech, and Serum Institute of India.

• M&A and Partnership Screening: Identify strategic opportunities involving vaccine manufacturers, biotechnology companies, research collaborations, joint ventures, and portfolio expansion.

• Technology and Portfolio Evaluation: Compare opportunities across mRNA, viral vector, recombinant, and other vaccine platforms, including applications in respiratory diseases, pediatric immunization, and adult and geriatric vaccination.

Metadata

• Update Frequency: One-time syndicated research report; ongoing update frequency is not specified.

• Data Source(s): Primary expert interviews conducted on an aggregated basis, proprietary secondary research databases, and industry sources.

• Original Publisher of data: Next Move Strategy Consulting.

• Geographic coverage: Global, including North America, Europe, Asia-Pacific, and other regions identified in the source report. Confirm detailed country-level coverage against the full report.

• Is historical data "point-in-time": Historical figures reflect estimates for their stated reference periods. Forecast values are projections for the specified forecast period.

• Data Set(s) Format(s): PDF / Excel.

• Raw or scraped data: No. This is syndicated analyst research, not a raw or scraped dataset.

• Number of companies/brands covered: 15 Companies (Same for all Keywords). Confirm the exact company count against the final report before publication.

Key Data Points

• Aging Population: Increasing demand for preventive immunization among older adults supports demand for vaccines targeting influenza, pneumonia, shingles, and other infectious diseases.

• Chronic Disease Prevalence: Growing incidences of diabetes, cardiovascular diseases, and respiratory disorders increase the importance of preventive vaccination for vulnerable populations.

• Rising Healthcare Expenditure: Higher healthcare spending supports immunization programs, vaccine research and development, healthcare infrastructure, and distribution capabilities.

Additional market dynamics: Stringent regulatory requirements can create approval and compliance challenges, while mRNA vaccine technologies present opportunities for new immunization applications and product development.

Pricing Information

The report is offered as a file-based syndicated research product. Availability of single-user, multi-user, and enterprise license tiers and applicable pricing should be confirmed with Next Move Strategy Consulting. Pricing is governed by the applicable AWS Data Exchange offer and license terms.

Regulatory and Compliance Information

This report is built from aggregated, publicly available and licensed secondary sources, supplemented by expert interviews conducted on an aggregated basis. It contains no individually identifiable personal data. Market estimates and forecasts are intended for research and analytical purposes.

Subscription Verification

AWS Data Exchange subscription verification applies to this public offer. Subscribers must confirm that they are not located in a restricted country and are not a covered party, as required by the applicable AWS subscription verification process